Pharmaceuticals

Biosimilar Growth Hormones Market Outlook 2026–2030

March 18, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Biosimilar Growth Hormones Market Expected To Change Between 2026 And 2030?

The biosimilar growth hormones market has witnessed significant expansion in recent years. Its valuation is anticipated to increase from $0.89 billion in 2025 to $0.98 billion in 2026, progressing at a compound annual growth rate (CAGR) of 10.1%. This historical development can be attributed to the elevated costs associated with branded growth hormone therapies, the rising incidence of growth hormone deficiency, a surge in diagnoses of pediatric growth disorders, limited access to budget-friendly treatment options, and a dependency on administration within hospital settings.

The biosimilar growth hormones market is anticipated to experience substantial expansion over the coming years, with its valuation projected to reach $1.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.5%. This growth during the forecast period is primarily driven by factors such as the expiration of patents for branded growth hormones, a rise in approvals for biosimilars, the broadening scope of self-administration therapies, increased public awareness regarding growth disorders, and a surge in healthcare expenditure within emerging markets. Significant trends expected during this period include the increased uptake of cost-effective biosimilar growth hormones, an escalating demand for both pediatric and adult growth hormone treatments, a stronger preference for self-administration through subcutaneous routes, the expansion of online pharmacies and specialized clinics, and enhanced regulatory acceptance of biosimilars.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

What Drivers Are Expected To Influence The Biosimilar Growth Hormones Market During The Forecast Period?

The rising number of children affected by growth hormone deficiency is stimulating the expansion of the global biosimilar growth hormone market. This deficiency occurs due to damage to the pituitary gland or hypothalamus, which can be the result of an abnormal formation present at birth (congenital) or an issue that developed during or after birth (acquired). For instance, in September 2023, as per Hormones Australia by the Endocrine Society of Australia (ESA), an Australia-based national authority focused on treating endocrine-related conditions and diseases, growth hormone deficiency is estimated to impact 2 to 3 out of every 10,000 people. Therefore, the growing prevalence of growth deficiencies in children is a key driver for the biosimilar growth hormones industry’s development.

How Is The Biosimilar Growth Hormones Market Structured Across Different Segments?

The biosimilar growth hormones market covered in this report is segmented –

1) By Route Of Administration: Subcutaneous, Intramuscular, Oral

2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications

3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

Subsegments:

1) By Subcutaneous: Self-administration, Professional Administration

2) By Intramuscular: Pediatric Care, Adult Care

3) By Oral: Tablets, Capsules

Which Trends Are Shaping The Future Of The Biosimilar Growth Hormones Market?

Leading companies operating in the biosimilar growth hormones market are developing innovative solutions, such as human growth hormone, with the aim of boosting treatment efficacy and affordability for those with growth hormone deficiencies. Growth hormone solutions are medical treatments or supplements designed to either stimulate or replace human growth hormone (HGH) in the body, addressing both growth deficiencies and anti-aging needs. For example, in June 2023, Pfizer Inc., a US-based pharmaceutical company, and OPKO Health Inc., a US-based healthcare company, obtained US Food and Drug Administration (FDA) approval for NGENLA (somatrogon-ghla). This particular product is a once-weekly injectable human growth hormone treatment tailored for pediatric patients diagnosed with growth hormone deficiency (GHD). This long-acting growth hormone therapy provides an alternative to conventional daily injections, which is expected to improve patient adherence and convenience for both patients and caregivers. The approval stemmed from clinical studies that demonstrated its efficacy and safety, marking a notable advancement in growth hormone therapies.

Which Major Players Dominate The Biosimilar Growth Hormones Market?

Major companies operating in the biosimilar growth hormones market are Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

Read the full biosimilar growth hormones market report here:

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Which Region Is Forecast To Lead The Biosimilar Growth Hormones Market In Terms Of Market Size?

North America was the largest region in the biosimilar growth hormone market in 2025. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biosimilar Growth Hormones Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3391&type=smp

Browse Through More Reports Similar to the Global Biosimilar Growth Hormones Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Parathyroid Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795